LOS ANGELES, Nov. 5, 2007 (PRIME NEWSWIRE) -- The November issue of EQUITIES is now available at newsstands nationwide and at bookstores such as Barnes and Noble, B.Dalton, and Books-A-Million. In it, the biotech market is examined by John Chambers, head of Acumen BioFin-the life-science division of the investment bank Rodman & Renshaw (Nasdaq:RODM).
As president of Acumen BioFin, Chambers is undoubtedly qualified to educate readers about the strategies behind biotech investing. In the interview, Chambers is asked about the state of the biotech industry and why diversifying in life sciences can be a safe bet in today's volatile markets. Chambers also delves into the decisions that investors and investment banks must make in evaluating attractive companies, and the strengths those companies should have.
Find out why Chambers claims "it pays not to have profits," and read about the top stock picks of two of Acumen BioFin's senior analysts, Elemer Piros (the No. 1 biotech analyst in The Wall Street Journal's 2007 Best on the Street survey) and Reni Benjamin. EQUITIES' Discovery Day Conference will be held on Dec. 7, 2007, at the Princeton Club in New York City.
About EQUITIES Global Communications Inc.
EQUITIES Magazine
Since 1951, EQUITIES Magazine has served both retail and institutional investors by examining industry trends, analyzing strategies and opportunities, and profiling financial leaders and emerging public companies. In recent years, we have expanded our editorial focus to include a wide range of issues that affect investors worldwide. Our global audience has increased dramatically owing to EQUITIES Europe, EQUITIES Digital Edition, and our website, which provides free real-time market quotes and a customizable, free, real-time portfolio-management interface.
Since 1981, EQUITIES Corporate Conferences have been staples within the industry, pairing the most exciting emerging companies in the world with sophisticated audiences of institutional and private investors.
EQUITIES has provided a voice and an audience to leaders in the global financial community for 56 years, and we remain the definitive investor's tool.
Safe Harbor -- This press release and the EQUITIES conference it announces are not to be construed, under any circumstances, by implication or otherwise, as an offer or an endorsement to sell or a solicitation to buy or trade in any commodities or securities therein named.
We note that each conference presenter paid EQUITIES. Any forward-looking statements made by the presenting companies are in no way endorsed by EQUITIES Global Communications Inc. and EQUITIES Magazine and we cannot guarantee any sort of performance for these stocks.
EQUITIES Global Communications Inc., EQUITIES Magazine and its employees are not, nor do they claim to be, registered investment advisors or broker/dealers. EQUITIES Conferences contain forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934 relating to companies' future operating results that are subject to certain risks that could cause results to differ materially from those projected. Readers are cautioned not to place undue reliance on these forward-looking statements. This publication undertakes no obligation to update these forward-looking statements. EQUITIES Magazine, its owners, employees, their families and associates may have investments in companies featured in this press release and in our conferences and may elect to sell these investments or purchase additional investments in the aforementioned companies at any time. Investors, conference audience members, web cast listeners and EQUITIES Magazine readers should do their own due diligence before investing in any securities mentioned. Investing in securities is speculative and carries a high degree of risk.